26 Nov 2021 12:59
IN BRIEF: Silence Therapeutics to delist from AIM next week
IN BRIEF: Silence Therapeutics to delist from AIM next week
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SLN.L Share News (SLN)
SLN Share
Price
SLN Share
News
SLN Share
Chat
SLN Share
Trades
SLN
Live RNS
SLN Share
Charts
SLN Broker
Ratings
SLN Directors
Deals
SLN Financial
Diary
SLN
Fundamentals
SLN Short
Positions
SLN
Media
SLN.L Information
- There is currently no data for SLN
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.26 Nov 2021 09:53
Silence Therapeutics to proceed with AIM delisting next week
(Sharecast News) - Silence Therapeutics updated the market on the planned cancellation of its shares on AIM on Friday, which it originally announced on 15 October.
Read more16 Nov 2021 12:23
TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note
TRADING UPDATES: Focusrite profit jumps; Gear4Music strikes bum note
Read more16 Nov 2021 11:39
Revenue, expenses rise in third quarter for Silence Therapeutics
(Sharecast News) - Silence Therapeutics said on Tuesday that its revenue increased by £1.2m year-on-year in its third quarter, as a result of the further advancement of its partner programmes, as well as the introduction of additional programmes with its partners.
Read more5 Nov 2021 18:40
IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics
IN BRIEF: Frazier Life picks up 3% interest in Silence Therapeutics
Read more5 Nov 2021 11:39
Frazier Life Sciences becomes 'important' new Silence Therapeutics shareholder
(Sharecast News) - Novel short interfering ribonucleic acid (siRNA) therapy developer Silence Therapeutics announced on Friday that healthcare-focussed investor Frazier Life Sciences Public Fund had purchased about $20m of its existing shares.
Read more25 Oct 2021 16:03
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
Read more22 Oct 2021 20:26
IN BRIEF: Silence Therapeutics reports solid progress across pipelines
IN BRIEF: Silence Therapeutics reports solid progress across pipelines
Read more15 Oct 2021 15:40
CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh
CORRECT: Silence Therapeutics to delist from AIM; teams with Hansoh
Read more15 Oct 2021 14:15
IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh
IN BRIEF: Silence Therapeutics to delist from AIM; unites with Hansoh
Read more15 Oct 2021 12:23
Silence Therapeutics inks collaboration deal with Hansoh Pharmaceutical
(Sharecast News) - Silence Therapeutics announced a collaboration with Hansoh Pharmaceutical Group on Friday, to develop short interfering ribonucleic acids (siRNAs) for three undisclosed targets, leveraging its proprietary 'mRNAi GOLD' platform.
Read more1 Sep 2021 09:30
Silence promotes John Strafford to head new product development
(Sharecast News) - Silence Therapeutics announced the appointment of John Strafford to the newly-created role of senior vice-president of business development, alliance management and new product development on Wednesday, effective immediately.
Read more12 Aug 2021 13:56
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca
IN BRIEF: Silence Therapeutics revenue up, new targets with AstraZeneca
Read more12 Aug 2021 09:37
Silence Therapeutics losses widen as it progresses programmes
(Sharecast News) - Silence Therapeutics reported revenues from collaborations of £5.8m in its first half on Thursday, up from £1.1m year-on-year, which it put down to its work with AstraZeneca and Mallinckrodt.
Read more5 Aug 2021 16:18
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more